UPDATED Jul 25, 2024
Discover U.S. Pharmaceuticals & Biotech Growth Stocks that are on the NYSE and NASDAQ. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
SBFM | US$0.30 | 0.03% | -99.3% | US$7.1m | US$15.00 | PB0.3x | E171.1% | n/a | ||
SNDL | US$2.13 | 1.7% | 44.9% | US$588.0m | US$3.62 | PB0.6x | E158.5% | n/a | ||
ASRT | US$1.47 | -9.8% | -72.5% | US$144.6m | US$3.19 | PB1x | E155.1% | n/a | ||
PHIO | US$3.85 | -12.0% | -84.1% | US$1.8m | US$36.00 | PB0.4x | E152.5% | n/a | ||
MLAB | US$108.19 | 0.7% | -15.4% | US$586.7m | US$118.00 | PS2.7x | E138.5% | 0.6% | ||
LFCR | US$6.07 | 19.3% | -39.8% | US$178.1m | US$6.00 | PS1.8x | E138.1% | n/a | ||
SAVA | US$12.75 | 25.2% | -37.5% | US$561.8m | n/a | PB7.8x | E134.7% | n/a | ||
CDMO | US$10.32 | 8.6% | -19.6% | US$597.0m | US$12.50 | PS4.7x | E132.2% | n/a | ||
NBY | US$1.94 | -4.0% | -92.1% | US$2.5m | US$58.63 | PE-0.1x | E124.5% | n/a | ||
VCYT | US$23.42 | -7.4% | -18.2% | US$1.8b | US$29.83 | PS4.8x | E122.0% | n/a | ||
AMRX | US$7.38 | 0.8% | 143.6% | US$2.3b | US$8.33 | PE-13.5x | E118.3% | 0% | ||
ETON | US$3.55 | -1.1% | 25.4% | US$91.2m | US$8.00 | PE99.9x | E117.7% | n/a | ||
EVOK | US$0.48 | -11.6% | -70.6% | US$4.3m | US$7.00 | PB1.2x | E110.6% | n/a | ||
YCBD | US$0.60 | -3.0% | -55.5% | US$2.4m | US$2.00 | PB0.8x | E108.4% | n/a | ||
HBIO | US$3.25 | -6.1% | -32.6% | US$143.3m | US$7.00 | PS1.3x | E106.7% | n/a | ||
BHC | US$5.88 | -20.3% | -37.2% | US$2.1b | US$9.44 | PE-4.7x | E104.9% | n/a | ||
CTKB | US$6.50 | 1.9% | -27.0% | US$824.4m | US$9.50 | PS4.2x | E100.6% | n/a | ||
CDXC | US$3.19 | 15.6% | 86.5% | US$242.3m | US$6.34 | PS2.9x | E99.5% | n/a | ||
MRVI | US$8.51 | -5.4% | -25.5% | US$2.1b | US$10.75 | PS4.1x | E97.7% | n/a | ||
PRPH | US$3.03 | -5.6% | -58.1% | US$59.3m | US$18.50 | PS2x | E97.4% | 0% | ||
AYTU | US$2.70 | -5.3% | 63.6% | US$16.4m | US$8.00 | PB0.5x | E96.2% | n/a | ||
ALVO | US$11.60 | -3.2% | 17.9% | US$3.6b | US$17.50 | PS30.6x | E96.1% | n/a | ||
ELAN | US$12.82 | -0.4% | 5.7% | US$6.4b | US$18.93 | PS1.5x | E90.4% | n/a | ||
ANIK | US$28.31 | 0.9% | 15.2% | US$416.7m | US$31.00 | PS2.5x | E88.0% | n/a |